ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 164 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $217,000 | -32.6% | 5,064 | 0.0% | 0.39% | -17.6% |
Q2 2019 | $322,000 | -8.3% | 5,064 | 0.0% | 0.48% | 0.0% |
Q1 2019 | $351,000 | +51.3% | 5,064 | -5.2% | 0.48% | -6.8% |
Q4 2018 | $232,000 | -50.4% | 5,339 | -13.0% | 0.51% | -54.3% |
Q3 2018 | $468,000 | -3.5% | 6,134 | -2.8% | 1.12% | +6.2% |
Q2 2018 | $485,000 | +30.4% | 6,311 | -13.4% | 1.05% | +44.1% |
Q1 2018 | $372,000 | -5.3% | 7,291 | -13.9% | 0.73% | +114.7% |
Q4 2017 | $393,000 | -38.0% | 8,472 | -28.8% | 0.34% | -40.2% |
Q3 2017 | $634,000 | +66.0% | 11,899 | +93.3% | 0.57% | +62.6% |
Q2 2017 | $382,000 | -53.8% | 6,157 | -49.5% | 0.35% | -43.0% |
Q1 2017 | $827,000 | +8.2% | 12,201 | +12.3% | 0.61% | +0.8% |
Q4 2016 | $764,000 | +52.2% | 10,864 | +53.6% | 0.61% | +116.0% |
Q3 2016 | $502,000 | +45.1% | 7,074 | 0.0% | 0.28% | -15.6% |
Q2 2016 | $346,000 | -59.5% | 7,074 | -47.6% | 0.33% | -49.5% |
Q1 2016 | $855,000 | -7.3% | 13,500 | +50.0% | 0.66% | -9.5% |
Q2 2015 | $922,000 | +23.8% | 9,000 | -25.0% | 0.73% | +17.0% |
Q1 2015 | $745,000 | – | 12,000 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |